The API, or active pharmaceutical ingredient, is the drug itself. In order to create a drug with high bioavailability solid dispersion is often necessary. In order to address this problem, we must take a look at the popular pharmaceutical materials, API or excipients. These materials have similar densities and molecular weights which makes structural imaging difficult.


DigiM has developed a contrast-enhanced imaging technique to specifically tackle this challenge, and helped several customers in better understanding their solid dosage formulation with both crystalline and amorphous drugs.